These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 8882471)
61. De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study. Jonaitis L; Kupčinskas J; Kiudelis G; Kupčinskas L Medicina (Kaunas); 2010; 46(7):454-9. PubMed ID: 20966617 [TBL] [Abstract][Full Text] [Related]
62. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Ford A; Delaney B; Forman D; Moayyedi P Cochrane Database Syst Rev; 2003; (4):CD003840. PubMed ID: 14583996 [TBL] [Abstract][Full Text] [Related]
63. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Ching CK; Leung KP; Yung RW; Lam SK; Wong BC; Lai KC; Lai CL Gut; 1996 May; 38(5):675-8. PubMed ID: 8707111 [TBL] [Abstract][Full Text] [Related]
64. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control. Schütze K; Hentschel E; Hirschl AM Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998 [TBL] [Abstract][Full Text] [Related]
65. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic]. Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978 [TBL] [Abstract][Full Text] [Related]
66. Critical issues in the pathophysiology and management of peptic ulcer disease. Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166 [TBL] [Abstract][Full Text] [Related]
68. Eradication of Helicobacter pylori has no effect on gastric acidity in duodenal ulcer patients--evaluation of 24-h pH monitoring. Rácz I; Szabó A; Csöndes M; Pécsi G; Goda M J Physiol Paris; 2001; 95(1-6):469-75. PubMed ID: 11595477 [TBL] [Abstract][Full Text] [Related]
69. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Ford AC; Delaney BC; Forman D; Moayyedi P Cochrane Database Syst Rev; 2006 Apr; (2):CD003840. PubMed ID: 16625592 [TBL] [Abstract][Full Text] [Related]
70. Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease. Tomita T; Fukuda Y; Tamura K; Tanaka J; Hida N; Kosaka T; Hori K; Sakagami T; Satomi M; Shimoyama T Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():204-9. PubMed ID: 11966543 [TBL] [Abstract][Full Text] [Related]
71. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Ford A; Delaney B; Forman D; Moayyedi P Cochrane Database Syst Rev; 2004 Oct; (4):CD003840. PubMed ID: 15495066 [TBL] [Abstract][Full Text] [Related]
72. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers. Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958 [TBL] [Abstract][Full Text] [Related]
73. The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people. Pilotto A; Franceschi M; Leandro G; DiMario F; Soffiati G; Scagnelli M; Bozzola L; Fabrello R; Valerio G J Am Geriatr Soc; 1996 Jun; 44(6):665-70. PubMed ID: 8642157 [TBL] [Abstract][Full Text] [Related]
74. Association of serum pepsinogens and gastrin-17 with Zhou JP; Liu CH; Liu BW; Wang YJ; Benghezal M; Marshall BJ; Tang H; Li H Front Cell Infect Microbiol; 2022; 12():980399. PubMed ID: 36051244 [TBL] [Abstract][Full Text] [Related]
75. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. McColl KE; Fullarton GM; Chittajalu R; el Nujumi AM; MacDonald AM; Dahill SW; Hilditch TE Scand J Gastroenterol; 1991 Mar; 26(3):339-46. PubMed ID: 1853158 [TBL] [Abstract][Full Text] [Related]
76. Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients. Yamamoto S; Kaneko H; Konagaya T; Mori S; Kotera H; Hayakawa T; Yamaguchi C; Uruma M; Kusugami K; Mitsuma T Helicobacter; 2001 Jun; 6(2):136-45. PubMed ID: 11422469 [TBL] [Abstract][Full Text] [Related]
77. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication. Iijima K; Koike T; Abe Y; Ara N; Uno K; Imatani A; Ohara S; Shimosegawa T J Gastroenterol; 2009; 44(8):819-25. PubMed ID: 19440811 [TBL] [Abstract][Full Text] [Related]
78. Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Chittajallu RS; Dorrian CA; Ardill JE; McColl KE Scand J Gastroenterol; 1992; 27(1):20-4. PubMed ID: 1736337 [TBL] [Abstract][Full Text] [Related]
79. Short report: twenty-four-hour hyperpepsinogenaemia in Helicobacter pylori-positive subjects is abolished by eradication of the infection. Fraser AG; Prewett EJ; Pounder RE; Samloff IM Aliment Pharmacol Ther; 1992 Jun; 6(3):389-94. PubMed ID: 1600055 [TBL] [Abstract][Full Text] [Related]
80. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme. Malfertheiner P; Dent J; Zeijlon L; Sipponen P; Veldhuyzen Van Zanten SJ; Burman CF; Lind T; Wrangstadh M; BayerdOrffer E; Lonovics J Aliment Pharmacol Ther; 2002 Aug; 16(8):1431-42. PubMed ID: 12182742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]